Start with alternate-day applications
It is not what is a GLP-1 drug? It is what changes for me? This piece Part 6 of our GLP-1 series for India answers exactly that, using Indian treatment patterns, Indian real-world data, and the practical realities of adjusting medicines you have likely been taking for a long time
However, their complexity demands equally sophisticated analytical and development strategies
The bigger picture: GLP-1 therapies are driving innovation at the intersection of endocrinology, cardiology, and obesity managementand reshaping pharma pipelines globally
We used the methods of Wan et al
Semaglutide is a glucagon-like peptide 1 (GLP-1) receptor agonist that helps to reduce appetite and food cravings, improve insulin and glucose levels, and delay gastric emptying